Lomas D A
Respiratory Medicine Unit, Department of Medicine, University of Cambridge, Wellcome Trust Centre for Molecular Mechanisms in Disease, Cambridge Institute for Medical Research, UK.
Respir Med. 2000 Aug;94 Suppl C:S3-6. doi: 10.1053/rmed.2000.0850.
Alpha1-antitrypsin deficiency results from point mutations that distort the structure of the protein to allow a unique protein-protein interaction that we have termed loop-sheet polymerization. Polymers of Z alpha1-antitrypsin accumulate within hepatocytes to form inclusion bodies that are associated with juvenile cirrhosis and hepatocellular carcinoma. The lack of circulating protein predisposes the Z alpha1-antitrypsin homozygote to emphysema. This polymerization process also occurs in variants of other members of the serine proteinase inhibitor (serpin) superfamily, antithrombin, C1-inhibitor and alpha1-antichymotrypsin in association with thrombosis, angiooedema and chronic obstructive pulmonary disease respectively, and we have recently shown that it underlies a novel inclusion body dementia. Understanding this mechanism of polymerization allows rational drug design to block the protein-protein linkage and so ameliorate the associated disease.
α1-抗胰蛋白酶缺乏症是由点突变引起的,这些突变会扭曲蛋白质的结构,从而产生一种独特的蛋白质-蛋白质相互作用,我们将其称为环片聚合。Z型α1-抗胰蛋白酶的聚合物在肝细胞内积聚,形成与青少年肝硬化和肝细胞癌相关的包涵体。循环蛋白的缺乏使Z型α1-抗胰蛋白酶纯合子易患肺气肿。这种聚合过程也发生在丝氨酸蛋白酶抑制剂(serpin)超家族的其他成员的变体中,抗凝血酶、C1抑制剂和α1-抗糜蛋白酶分别与血栓形成、血管性水肿和慢性阻塞性肺疾病相关,并且我们最近发现它是一种新型包涵体痴呆的基础。了解这种聚合机制有助于进行合理的药物设计,以阻断蛋白质-蛋白质连接,从而改善相关疾病。